The Doctor’s Advocate | Third Quarter 2017

Groundbreaking Research Funded by the Foundation

A study funded by a grant from The Doctors Company Foundation was recently honored by a national otolaryngology society.

Joseph Zenga, MD, resident with the Department of Otolaryngology–Head and Neck Surgery at Washington University and Barnes-Jewish Hospital in St. Louis, Missouri, received the Lawrence Boies MD Resident Research Award from the Triological Society at its meeting in New Orleans, Louisiana, for his podium presentation “Incidents and Complications of Postoperative Hemorrhage After Transoral Robotic Surgery.”

“We are immensely pleased to enhance patient safety and support the practice of good medicine by providing the $10,000 grant that made this study possible,” said David B. Troxel, MD, board chairman of The Doctors Company Foundation and medical director of The Doctors Company. “By supporting this research on the risks of postoperative bleeding from transoral robotic surgery, we are shining a light on the risks and trends that others don’t see.”

Read the full press release at thedoctors.com/newsandinsights.

The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.

The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.

The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider considering the circumstances of the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.

The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.